Adalimumab for the prevention of recurrence after surgery for Crohn's disease.
Takayuki
T
Yamamoto
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D003424:Crohn Disease / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008297:Male
D000893:Anti-Inflammatory Agents; D061067:Antibodies, Monoclonal, Humanized